0001236031-14-000036.txt : 20140821
0001236031-14-000036.hdr.sgml : 20140821
20140821120904
ACCESSION NUMBER: 0001236031-14-000036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140819
FILED AS OF DATE: 20140821
DATE AS OF CHANGE: 20140821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KERSTEN GEERT R
CENTRAL INDEX KEY: 0001236030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 141057048
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2014-08-19
0
0000725363
CEL SCI CORP
cvm
0001236030
KERSTEN GEERT R
1
1
0
0
Chief Executive Officer
Convertible Note
4
2014-08-19
4
G
0
276014
0.01
A
2014-08-19
2015-07-06
Common Stock
276014
2309315
I
Trustee
Warrants
4
2014-08-19
4
G
0
164824
0.01
A
2014-08-19
2014-12-24
Common Stock
164824
2474139
I
Trustee
Warrants
5
2014-08-19
4
G
0
184930
0.01
A
2014-08-19
2015-01-06
Common Stock
184930
2659069
I
Trustee
Mr. Kersten is the trustee and one of the beneficiaries of a trust which, on August 19, 2014, received the following by assignment from Maximilian de Clara: (1) a promissory note in the principal amount of $1,104,056 which is convertible into shares of the Company common stock at a conversion price of $4.00 per share; (2) warrants which allow the trust to purchase up to 164,824 shares of the Company common stock at a price of $4.00 per share at any time prior to December 24, 2014; and (3) warrants which allow the trust to purchase up to 184,930 shares of the Company common stock at a price of $5.00 per share at any time prior to January 6, 2015. Mr. de Clara is the President and a director of the Company.
Geert Kersten
2014-08-21